Yes, I noticed that. There'll be an amendment required for sure. I also wouldn't put any money on the Scoping Study coming through this quarter either. Frankly I was amazed that they were able to spin-off WR1 successfully. Everything else always seems to occur months after forecasted dates. I do give them some leeway, though, where assays are concerned because so many companies are having trouble getting them through an obvious shortage of labs and trained personnel.
Yes, I noticed that. There'll be an amendment required for sure....
Add MTC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $46.29M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.5¢ | $39.35K | 157.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 193658 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 10000 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 25.0¢ | 24.5¢ | 233222 | ||
| Last updated 15.49pm 17/05/2024 ? | |||||
| MTC (ASX) Chart |